Viewing Study NCT02809768


Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2026-02-19 @ 4:52 AM
Study NCT ID: NCT02809768
Status: COMPLETED
Last Update Posted: 2017-03-09
First Post: 2016-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects
Sponsor: Eisai Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: E5501-A001-019
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators